4-minute read
Researchers at UC Davis Health are continuing to Phase 2 of a clinical trial for in utero surgery that uses stem cells to repair spina bifida defect, offering potential better outcomes.
4-minute read
Researchers at UC Davis Health are continuing to Phase 2 of a clinical trial for in utero surgery that uses stem cells to repair spina bifida defect, offering potential better outcomes.
3-minute read
Zane and Zeke are happy and thriving today after experiencing impossibly long odds of developing the same congenital heart defect. The exceptional care teams at Children’s Hospital Colorado provided cutting edge expertise and unwavering support for the entire family throughout both boys’ fight to survive.
2 minutes
An affordable and accessible test can provide pregnant women around the world an opportunity to understand their risk of preterm birth, allowing for healthier pregnancies and healthier babies.
4-minute read
Now that there is ever-growing potential to intervene medically before a child is born, it expands the utility of prenatal testing. Doctors can find ways to intervene earlier to improve outcomes.
3-minute read
University of California at San Francisco Hydrops Center of Excellence leads the way in Hydrops research. Funding from Brianna Marie and Fetal Health Foundations helps experts continue to deliver the latest in-utero treatments.
2-minute read
Dr. Teresa Harper, Maternal-Fetal Medicine Specialist at Children’s Hospital Colorado, tells us which 6 tests are most commonly relied on during pregnancy to help guide care and minimize risks.
2-minute read
Four years later, Ella is a thriving preschooler and big sister, thanks to Colorado Fetal Care Center. The Center is the only facility in the Rocky Mountain region to offer the complex procedure she underwent to remove a sacrococcygeal teratoma that was twice Ella’s size.
2-minute read
HDFN is a rare fetal syndrome that affects later pregnancies. Johnson & Johnson is pioneering research to help women at severe risk. Their clinical trial is currently enrolling women who are at risk for severe HDFN who have a history of severe HDFN in a prior pregnancy.